These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30593832)

  • 1. Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells.
    Ledo AM; Sasso MS; Bronte V; Marigo I; Boyd BJ; Garcia-Fuentes M; Alonso MJ
    J Control Release; 2019 Feb; 295():60-73. PubMed ID: 30593832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy.
    Sasso MS; Lollo G; Pitorre M; Solito S; Pinton L; Valpione S; Bastiat G; Mandruzzato S; Bronte V; Marigo I; Benoit JP
    Biomaterials; 2016 Jul; 96():47-62. PubMed ID: 27135716
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Gao Y; Shang W; Zhang D; Zhang S; Zhang X; Zhang Y; Yang R
    Front Immunol; 2019; 10():1661. PubMed ID: 31379854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells.
    Soong RS; Anchoori RK; Yang B; Yang A; Tseng SH; He L; Tsai YC; Roden RB; Hung CF
    Oncotarget; 2016 Oct; 7(42):68489-68502. PubMed ID: 27655678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C/EBPβ enhances immunosuppression activity of myeloid-derived suppressor cells by a P300-mediated acetylation modification.
    Wang W; Chen Y; Du R; Xia X; Zhang Y; Guo H; Ma J; Tian J; Wang S
    Inflamm Res; 2022 Dec; 71(12):1547-1557. PubMed ID: 36301341
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Gao Y; Sun W; Shang W; Li Y; Zhang D; Wang T; Zhang X; Zhang S; Zhang Y; Yang R
    Cancer Immunol Res; 2018 Nov; 6(11):1352-1363. PubMed ID: 30171135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules.
    Pinton L; Magri S; Masetto E; Vettore M; Schibuola I; Ingangi V; Marigo I; Matha K; Benoit JP; Della Puppa A; Bronte V; Lollo G; Mandruzzato S
    J Nanobiotechnology; 2020 Feb; 18(1):31. PubMed ID: 32066449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontline Science: Myeloid cell-specific deletion of Cebpb decreases sepsis-induced immunosuppression in mice.
    McPeak MB; Youssef D; Williams DA; Pritchett CL; Yao ZQ; McCall CE; El Gazzar M
    J Leukoc Biol; 2017 Aug; 102(2):191-200. PubMed ID: 28476751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid attenuates immunosuppressive function of myeloid-derived suppressor cells.
    Xie Z; Ago Y; Okada N; Tachibana M
    J Pharmacol Sci; 2018 Aug; 137(4):359-365. PubMed ID: 30177294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.
    Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A
    Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma.
    Xu Z; Ji J; Xu J; Li D; Shi G; Liu F; Ding L; Ren J; Dou H; Wang T; Hou Y
    FEBS J; 2017 Aug; 284(15):2410-2424. PubMed ID: 28605567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer.
    Takeyama Y; Kato M; Tamada S; Azuma Y; Shimizu Y; Iguchi T; Yamasaki T; Gi M; Wanibuchi H; Nakatani T
    Cancer Lett; 2020 Jun; 479():89-99. PubMed ID: 32200039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of myeloid-derived suppressor cells and cytokines GM-CSF, IL-10 and MCP-1 in dogs with malignant melanoma receiving a GD3-based immunotherapy.
    Hutchison S; Sahay B; de Mello SC; Sayour EJ; Lejeune A; Szivek A; Livaccari AM; Fox-Alvarez S; Salute M; Powers L; Milner RJ
    Vet Immunol Immunopathol; 2019 Oct; 216():109912. PubMed ID: 31446208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways.
    Guo X; Qiu W; Liu Q; Qian M; Wang S; Zhang Z; Gao X; Chen Z; Xue H; Li G
    Oncogene; 2018 Aug; 37(31):4239-4259. PubMed ID: 29713056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Multiple Cytokine Combinations and TGF-β on Differentiation and Functions of Myeloid-Derived Suppressor Cells.
    Lee CR; Lee W; Cho SK; Park SG
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29543758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AhR Activation Leads to Massive Mobilization of Myeloid-Derived Suppressor Cells with Immunosuppressive Activity through Regulation of CXCR2 and MicroRNA miR-150-5p and miR-543-3p That Target Anti-Inflammatory Genes.
    Neamah WH; Singh NP; Alghetaa H; Abdulla OA; Chatterjee S; Busbee PB; Nagarkatti M; Nagarkatti P
    J Immunol; 2019 Oct; 203(7):1830-1844. PubMed ID: 31492743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of immunosuppressive drug cyclosporine A on myeloid-derived suppressor cells in transplanted mice.
    Han C; Wu T; Na N; Zhao Y; Li W; Zhao Y
    Inflamm Res; 2016 Sep; 65(9):679-88. PubMed ID: 27147271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin.
    Zhou J; Donatelli SS; Gilvary DL; Tejera MM; Eksioglu EA; Chen X; Coppola D; Wei S; Djeu JY
    Sci Rep; 2016 Jul; 6():29521. PubMed ID: 27405665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells.
    Liu Q; Zhang M; Jiang X; Zhang Z; Dai L; Min S; Wu X; He Q; Liu J; Zhang Y; Zhang Z; Yang R
    Int J Cancer; 2011 Dec; 129(11):2662-73. PubMed ID: 21213211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.